Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604884 · ClinicalTrials.gov registry record
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
A clinical trial of Intracranial Aneurysm, sponsored by Medtronic Neurovascular Clinical Affairs.
- Recruiting
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT06604884 is a study of Intracranial Aneurysm that is actively recruiting participants, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 118 participants, below the 9,188-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06604884, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Medtronic Neurovascular Clinical Affairs.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.
Conditions Studied
Interventions
- DEVICE Treatment of Intracranial Aneurysms
Study Locations (2)
Georgia
- Wellstar Research Institute - Marietta
Michigan
- McLaren Healthcare - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2033-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06604884
The ClinicalTrials.gov registry entry for NCT06604884 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,188-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Treatment of Intracranial Aneurysms is the first listed.
NCT06604884 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Michigan.
Frequently Asked Questions
What is clinical trial NCT06604884 about?
NCT06604884 is a clinical study titled "NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study". The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shiel...
What is the current status of trial NCT06604884?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-12-12. Estimated completion is 2033-09.
What conditions does trial NCT06604884 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT06604884?
The interventions under investigation include: Treatment of Intracranial Aneurysms (DEVICE).
Who is sponsoring clinical trial NCT06604884?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06604884 being conducted?
This trial has 2 study locations across Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Product Surveillance Registry
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.